colorectal cancer
Conditions
Interventions
Gold Standard:In terms of reagent detection performance, we chose to compare it with Sanger sequencing.
In terms of clinical application performance, choose to compare with colonoscopy (and) or pathol
Index test:Human SDC2 and LIFR Gene Methylation Detection Kit (Fluorescent PCR Method)
Sponsors
Hubei Cancer Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet one of the following criteria: (1) Clinicians recommend colonoscopy for suspected cases of colorectal cancer or precancerous lesions; (2) Other gastrointestinal cancer patients include gastric cancer, liver cancer, esophageal cancer, bile duct cancer, pancreatic cancer, etc; 2. I voluntarily participate in this clinical trial and have signed a written informed consent form.
Exclusion criteria
Exclusion criteria: 1.Unable to cooperate with the sample collector; 2.The researchers believe that other reasons are not suitable for participants in this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Total compliance rate;Positive/negative predictive value;Positive/negative likelihood ratio;Kappa value;Positivity rate;Negative concordance rate; | — |
Countries
China
Contacts
Public ContactHu Jianhua
Hubei Cancer Hospital
Outcome results
None listed